Zynex Inc: (OTC: ZYXI)
$0.43
-0.00 (-0.02%)
Volume 44,787
May 22 03:45 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 0.37 - 0.43 |
| 52wk Low - High | 0.37 - 1.01 |
| Previous Close | 0.43 |
| Avg. Volume | 14,928 |
| Industry | MED PRODUCTS |
| Market Cap | 13.49 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.54 |
| PE (Forward) | 17.32 |
| Current Year Est. | 0.03 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
NA |
Zacks Industry Rank
|
177 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 17.32 |
| PEG Ratio | NA |
| Current Year Est. | 0.03 |
| Current Quarter Estimate | 0.01 |
| Most Accurate Estimate | 0.01 |
| Earnings ESP |
0.00% |
| Next Earnings Report Date | 08-06-2013 |
| EPS Last Year | 0.03 |
| Expected Earnings Growth | NA |
Company Description
Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.01 | 0.01 | 0.03 | 0.07 |
| Number of Estimates | 2 | 2 | 2 | 2 |
| Low Estimate | 0.01 | 0.01 | 0.02 | 0.04 |
| High Estimate | 0.02 | 0.01 | 0.03 | NA |
| Year Ago EPS | 0.02 | 0.01 | 0.05 | 0.03 |
| EPS Growth | -25.00% | 0.00% | -50.00% | 160.00% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ZYNEX INC | ZYXI | 0.43 | |
|
| ATRICURE INC | ATRC | 8.99 | |
|
| CONCEPTUS INC | CPTS | 30.98 | |
|
| INVIVO THERAPT | NVIV | 2.90 | |
|
| TRANS1 INC | TSON | 1.59 | |
|
| ABAXIS INC | ABAX | 44.22 | |
|
| ADVAXIS INC | ADXS | 0.05 | |
|
| BAXTER INTL | BAX | 73.04 | |
|
| BIO-RAD LABS -A | BIO | 116.12 | |
|
| BIOLIFE SOL INC | BLFS | 0.38 | |
|
Sector:Medical>> Industry:MED PRODUCTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
ZYXI Q1: Revenue and Margins Impacted
May 09, 2013
ZYXI Revenue Growth Continues
Mar 14, 2013
Q3 Results In-Line, Maintaining Outlook/Recommendation
Nov 07, 2012
ZYXI - Q2 2012 Financial Results
Aug 08, 2012
Report Not Available
Financials
| EPS TTM | 0.03 |
| Sales | 40 |
| Net Income | 1 |
| Price/Earnings | 14.43 |
| Price/Book | 1.14 |
| Price/Cash Flow | NA |
| Price/Sales | 0.35 |
News
First Niagara Financial Group: 52-Week High Recently Eclipsed (FNFG) - Financial News Netwfork Online - 52-Week High-Lows
May 22, 2013
Pre-Market Analysis on FNFG, PBCT, HCBK and CFFN - Accesswire-Tnw
May 16, 2013
Shares of First Niagara Financial Group Rise to a New 52-Week High - Financial News Netwfork Online - 52-Week High-Lows
May 14, 2013
First Niagara Financial Group Up 18.0% Since SmarTrend Uptrend Call (FNFG) - Comtex Smartrend(R)
May 7, 2013
First Niagara Financial Group: 52-Week High Recently Eclipsed (FNFG) - Financial News Netwfork Online - 52-Week High-Lows
May 7, 2013
Shares of First Niagara Financial Group Receive a Boost, Up 2.3% - Financial News Network Online - Market Movers
May 7, 2013
Bottom 5 Companies in the Thrifts & Mortgage Finance Industry with the Lowest Relative Performance (BRKL, FBC, VPFG, CFFN, FNFG) - Financial News Network Online - News Corner
May 3, 2013
Raymond James's Rating Change Only Had Short-term Impact, First Niagara Financial Group Down 1.8% (FNFG) - Financial News Network Online - News Corner
May 2, 2013
Broker Recommendations
| Current ABR | 1.50 |
| ABR (Last Week) | 1.50 |
| # of recs in ABR | 2 |
| Average Target Price | 0.85 |
| Industry Rank by ABR | 177 out of 265 |
| Rank in Industry | 5 out of 73 |
